Development and measurement of guideline-based indicators for patients with non-hodgkin's lymphoma

Journal of Clinical Oncology

Volumn 29, Issue 11, 2011, Pages 1436-1444

  Wennekes, Lianne ^a,b,c   Ottevanger, Petronella B ^a,b,c   Raemaekers, John M ^a,b,c   Schouten, Harry C ^a,b,c   De Kok, Marjorie W E ^a,b,c   Punt, Cornelis J A ^a,b,c   Grol, Richard P ^a,b,c   Wollersheim, Hub C ^a,b,c   Hermens, Rosella P ^a,b,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Integraal Kankercentrum Oost   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ABDOMINAL RADIOGRAPHY; AGED; ARTICLE; BONE MARROW EXAMINATION; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL INDICATOR; COMORBIDITY; CONTROLLED STUDY; DELPHI STUDY; FEMALE; GUIDELINE BASED INDICATOR; HEALTH CARE QUALITY; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NECK; NETHERLANDS; NONHODGKIN LYMPHOMA; PATHOLOGY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIODIAGNOSIS; SCORING SYSTEM; THORAX EXAMINATION;

AGE FACTORS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DELPHI TECHNIQUE; DIAGNOSTIC IMAGING; GUIDELINE ADHERENCE; HUMANS; LOGISTIC MODELS; LYMPHOMA, NON-HODGKIN; NEOPLASM STAGING; NETHERLANDS; PATIENT CARE PLANNING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; QUALITY INDICATORS, HEALTH CARE; REGISTRIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 79954986887     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.30.1622     Document Type: Article

References (32)

1. Lu P: Staging and classification of lymphoma. Semin Nucl Med 35:160-164, 2005 (Pubitemid 41138135)
2. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2009. CA Cancer J Clin 59:225-249, 2009
3. Bastion Y, Sebban C, Berger F, et al: Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol 15:1587-1594, 1997 (Pubitemid 27167397)
4. Cabanillas F, Velasquez WS, Hagemeister FB, et al: Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma. Blood 79: 1024-1028, 1992
5. Yuen AR, Kamel OW, Halpern J, et al: Long-term survival after histologic transformation of low-grade follicular lymphoma. J Clin Oncol 13:1726-1733, 1995
6. Guideline non-Hodgkin lymphoma (richtlijn non-Hodgkin lymfoom), Van Zuiden Communications, B.V., 2004
7. Hiddemann W, Dreyling M, Stahel RA: Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma. Ann Oncol 16:i56-i57, 2005 (suppl 1) (Pubitemid 40872990)
8. The Haematology Task Force of the British Committee for Standards in Haematology: Guidelines on diagnosis and therapy nodal non-Hodgkin's lymphoma in 2002. http://www.bcshguidelines.com/ documents/nodal-NHL-bcsh-2003.pdf
9. Jost LM, Stahel RA: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of relapsed large cell non-Hodgkin's lymphoma. Ann Oncol 16:i60-i61, 2005 (suppl 1) (Pubitemid 40872992)
10. Jost LM, Kloke O, Stahel RA: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma. Ann Oncol 16:i58-i59, 2005 (suppl 1) (Pubitemid 40872991)
11. Hallek M, Stahel RA, Greil R: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia. Ann Oncol 16:i50-i51, 2005 (suppl 1) (Pubitemid 40872987)
12. Cheson BD, Horning SJ, Coiffier B, et al: Report of international workshop to standardize response criteria for non-Hodgkin's lymphoma: NCISponsored International Working Group. J Clin Oncol 17:1244-1253, 1999 (Pubitemid 29162950)
13. Australian Cancer Network Diagnosis and Management of Lymphoma Guidelines Working Party: The Cancer Council Australia and Australian Cancer Network: Clinical practice guidelines for the diagnosis and management of lymphoma in 2005. http:// www.nhmrc.gov.au/-files-nhmrc/file/publications/ synopses/cp107/cp107.pdf
14. Bero LA, Grilli R, Grimshaw JM, et al: Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings-The Cochrane Effective Practice and Organization of Care Review Group. BMJ 317:465-468, 1998 (Pubitemid 28368041)
15. Grol R, Dalhuijsen J, Thomas S, et al: Attributes of clinical guidelines that influence use of guidelines in general practice: Observational study. BMJ 317:858-861, 1998 (Pubitemid 28434555)
16. Lawrence M, Olesen F: Indicators of quality in health care. Eur J Gen Pract 3:103-108, 1997
17. Hermens RP, Ouwens MM, Vonk-Okhuijsen SY, et al: Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: A first step toward implementing a multidisciplinary, evidence-based guideline. Lung Cancer 54:117-124, 2006
18. Ouwens MM, Marres HA, Hermens RR, et al: Quality of integrated care for patients with head and neck cancer: Development and measurement of clinical indicators. Head Neck 29:378-386, 2007 (Pubitemid 46623503)
19. Wei JT, Miller EA, Woosley JT, et al: Quality of colon carcinoma pathology reporting: A process of care study. Cancer 100:1262-1267, 2004 (Pubitemid 38325955)
20. Spencer BA, Miller DC, Litwin MS, et al: Variations in quality of care for men with earlystage prostate cancer. J Clin Oncol 26:3735-3742, 2008
21. Bilimoria KY, Bentrem DJ, Lillemoe KD, et al: Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Natl Cancer Inst 101:848-859, 2009
22. Cheng SH, Wang CJ, Lin JL, et al: Adherence to quality indicators and survival in patients with breast cancer. Med Care 47:217-225, 2009
23. Ouwens MM, Hermens RR, Termeer RA, et al: Quality of integrated care for patients with nonsmall cell lung cancer: Variations and determinants of care. Cancer 110:1782-1790, 2007 (Pubitemid 47557303)
24. Campbell SM, Cantrill JA, Roberts D: Prescribing indicators for UK general practice: Delphi consultation study. BMJ 321:425-428, 2000 (Pubitemid 30609449)
25. de Vet HC, Terwee CB, Knol DL, et al: When to use agreement versus reliability measures. J Clin Epidemiol 59:1033-1039, 2006 (Pubitemid 44376776)
26. Koch GG, Landis JR, Freeman JL, et al: A general methodology for the analysis of experiments with repeated measurement of categorical data. Biometrics 33:133-158, 1977 (Pubitemid 8054848)
27. Mourad SM, Nelen WL, Hermens RP, et al: Variation in subfertility care measured by guidelinebased performance indicators. Hum Reprod 23: 2493-2500, 2008
28. Charlson M, Szatrowski TP, Peterson J, et al: Validation of a combined comorbidity index. J Clin Epidemiol 47:1245-1251, 1994 (Pubitemid 24361532)
29. Yates JW, Chalmer B, McKegney FP: Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45:2220-2224, 1980 (Pubitemid 10150440)
30. Berrios-Rivera JP, Fang S, Cabanillas ME, et al: Variations in chemotherapy and radiation therapy in a large nationwide and community-based cohort of elderly patients with non-Hodgkin lymphoma. Am J Clin Oncol 30:163-171, 2007 (Pubitemid 46573252)
31. Friedberg JW, Taylor MD, Cerhan JR, et al: Follicular lymphoma in the United States: First report of the national LymphoCare study. J Clin Oncol 27:1202-1208, 2009
32. Grol R, Grimshaw J: From best evidence to best practice: Effective implementation of change in patients' care. Lancet 362:1225-1230, 2003 (Pubitemid 37255352)